Lilly Eli Aktie - LLY

Professionelle Tools für Privatanleger.

Premium

Current Price

769,00

Gebot

769,30

Fragen

770,50

Volumen

4.395

767,50 Tagesbereich 778,60

40,43 52-Wochen-Bereich 891,00

Marktkapitalisierung

729,143B

Handelsende

778,50

Handelsbeginn

778,30

Letzte Trade

769

Letzter Handelszeitpunkt

10:46:16

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

3.703

Ausgegebene Aktien

948.169.999

Dividendenrendite

0.89%

Kurs-Gewinn-Verhältnis

79,20

Gewinn pro Aktie (EPS)

11,17

Erlöse

45,04B

Nettogewinn

10,59B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.lilly.com

Hauptsitz

Indianapolis, Indiana, USA

Gegründet

Lilly Eli and Co is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker LLY. The last closing price for Lilly Eli was 778,50 €. Over the last year, Lilly Eli shares have traded in a share price range of 40,43 € to 891,00 €.

Lilly Eli currently has 948.169.999 shares in issue. The market capitalisation of Lilly Eli is 738,15 € billion. Lilly Eli has a price to earnings ratio (PE ratio) of 79.20.

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

SAN DIEGO, INDIANAPOLIS and WALTHAM, Mass., Feb. 25, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), Eli Lilly and...

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Health Education Answers recognized as an effective online tool by eHealthcare Leadership Awards and Web Marketing Association INDIANAPOLIS, Feb...

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

CHICAGO, Jan. 22 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for BRK.B, PM, AFL, LLY, and DHI. Seven Summits Strategic...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	38.5	5.27036276523	730.5	778.6	723.4	2161	769.93981953	DE
4	11.6	1.53155532083	757.4	778.6	586	4712	681.35659784	DE
12	-9.6	-1.23298227588	778.6	891	40.43	3703	769.42225784	DE
26	-59.6	-7.19285541878	828.6	891	40.43	4319	755.66430412	DE
52	81.2	11.8057574876	687.8	891	40.43	4554	777.80889684	DE
156	498.85	184.656672219	270.15	891	40.43	3091	661.32561373	DE
260	617.28	406.854732402	151.72	891	40.43	2238	577.35672987	DE

LLY - Frequently Asked Questions (FAQ)

What is the current Lilly Eli share price?

The current share price of Lilly Eli is 769,00 €

How many Lilly Eli shares are in issue?

Lilly Eli has 948.169.999 shares in issue

What is the market cap of Lilly Eli?

The market capitalisation of Lilly Eli is EUR 738,15B

What is the 1 year trading range for Lilly Eli share price?

Lilly Eli has traded in the range of 40,43 € to 891,00 € during the past year

What is the PE ratio of Lilly Eli?

The price to earnings ratio of Lilly Eli is 79,2

What is the cash to sales ratio of Lilly Eli?

The cash to sales ratio of Lilly Eli is 18,62

What is the reporting currency for Lilly Eli?

Lilly Eli reports financial results in USD

What is the latest annual turnover for Lilly Eli?

The latest annual turnover of Lilly Eli is USD 45,04B

What is the latest annual profit for Lilly Eli?

The latest annual profit of Lilly Eli is USD 10,59B

What is the registered address of Lilly Eli?

The registered address for Lilly Eli is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204

What is the Lilly Eli website address?

The website address for Lilly Eli is www.lilly.com

Which industry sector does Lilly Eli operate in?

Lilly Eli operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
JJ80ASEP Medical Holdings Inc	0,36 € (64,01%)	222
7XTXTM Inc	0,0392 € (29,80%)	1,06k
1XNAYnvisible Interactive Inc	0,1375 € (25,57%)	708,49k
4CQASunrise Energy Metals Limited	0,326 € (23,48%)	2,69k
42FBAIML Innovations Inc	0,0648 € (21,35%)	10,35k
L7C2Windfall Geotek Inc	0,0045 € (-60,87%)	8,27k
LN00Cult Food Science Corp	0,0104 € (-50,00%)	750
3SHShunfeng International Clean Energy Limited	0,0014 € (-36,36%)	60k
SL51Vanguard Mining Corp	0,0666 € (-34,19%)	10
ATYArtemis Resources Limited	0,004 € (-27,27%)	25k
D7GNel ASA	0,20 € (0,20%)	1,56M
5YWBattery X Metals Inc	0,165 € (18,71%)	837,8k
TKAThyssenkrupp AG	10,16 € (3,04%)	782,7k
DRHDroneShield Limited	0,688 € (4,08%)	719,97k
1XNAYnvisible Interactive Inc	0,1375 € (25,57%)	708,49k

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Lilly Eli and Co (LLY)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Lilly Eli and Co

LLY Neueste Nachrichten

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

Lilly CEO Stresses Human Element in Driving Medical Innovation

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

LLY - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Lilly Eli and Co (LLY) Börsenkurse

Lilly Eli and Co (LLY)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Lilly Eli and Co

LLY Neueste Nachrichten

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

Lilly's Online, Interactive Health Education Program Receives Two Web Awards

Critical Alerts for Berkshire-Hathaway, Philip Morris International, AFLAC, Eli Lilly, and DR Horton Released by Seven Summits R

Lilly CEO Stresses Human Element in Driving Medical Innovation

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement

Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance

FDA Approves Lilly's Zyprexa for Two Adolescent Indications

FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

LLY - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich für ein Konto unter ADVFN

Werbung entfernen